首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Subconjunctival injection of triamcinolone acetonide in the management of corneal graft rejection and new vessels
【24h】

Subconjunctival injection of triamcinolone acetonide in the management of corneal graft rejection and new vessels

机译:结膜下注射曲安奈德治疗角膜移植排斥反应和新血管

获取原文
获取原文并翻译 | 示例
           

摘要

Graft rejection still remains one of the major complications of corneal transplantation. Various modalities such as topical steroid drops, topical cyclosporine, and systemic immunosuppression have been used to treat corneal graft rejection.We report a case of graft rejection successfully treated with a single dose of subconjunctival triam-cinolone acetonide (SCTA) and briefly review the use of subconjunctival steroids.
机译:移植物排斥仍然是角膜移植的主要并发症之一。局部激素治疗,局部环孢素治疗和全身免疫抑制等多种治疗方法已被用于治疗角膜移植物排斥反应。结膜下类固醇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号